We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Amazon, Alphabet, Apple, Twitter and Facebook
Read MoreHide Full Article
For Immediate Release
Chicago, IL – March 2, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Amazon (AMZN - Free Report) , Alphabet (GOOGL - Free Report) , Apple (AAPL - Free Report) , Twitter and Facebook .
Tech Roundup: Amazon in Healthcare, Google Pay Launches
Amazon selling over the counter medications and Alphabet rebranding and enhancing Android Pay as Google Pay were the top stories from last week.
The Amazon Drug Store
CNBC reported that Amazon quietly launched a line of over-the-counter (OTC) medications and generic drugs under the Basic Care brand back in August. The 60 products sold under the brand are currently exclusively manufactured by private label Perrigo and also include some generics sold under its GoodSense brand.
Over the counter medications are everyday things like cough syrups, allergy medicines or treatments for minor stomach disorders that don’t require a prescription. People generally don’t buy them til the last minute, something that may not change despite Amazon’s competitive pricing. This is the main challenge for Amazon in the segment. They comprise 31%, or $8.4 billion, of the U.S. OTC medication industry, according to Euromonitor.
The bigger and more regulated part of the market is generics and while there have been news reports off and on about Amazon’s interest in the area, this market will be harder to break into. But once it manages to make an entry, it will be much easier to buy prescription medicines on Amazon, especially for chronic or prolonged illnesses. This might be why the company recently launched an alliance with JPMorgan Chase and Berkshire Hathaway with the stated objective of lowering healthcare costs for everyone over the long term.
Google Pay
As announced earlier, Google is rebranding Android Pay as Google Pay and also incorporating Google Wallet P2P (now called Google Pay Send) services into it. The app’s Home tab displays your recent transactions and based on your shopping history and location, lists nearby places that accept Google Pay. There’s also a Cards tab that stores your debt, credit and loyalty card information, as well as ongoing offers.
You can shift through these with your Google account information and don’t need to share card details. Other than the supported brick-and-mortar outlets, Google Pay also allows you to pay online on partner sites like Airbnb,DoorDash, Hotel Tonight and Fandango.
For people already using Android Pay, the shift will simply be a software update. The Google Pay Send integration will happen gradually over the next few months, first in the U.S. and UK.
Other Stories-
Corporate
Analysts Weigh in on Apple: According to various media reports, UBS analyst Steven Milunovich thinks that Apple will likely spend its billons by buying back shares or combining that with higher dividends to become cash neutral by 2023. Speculation started after In the first scenario, it buys back 10% of its shares each year resulting in a 30% increase in the EPS by 2021 and in the second, its spends $30-60 billion on share buybacks while increasing the dividend yield to 3% from 1.6%. The analyst doesn’t think there’s a big acquisition on the horizon.
Analyst Sees Facebook Losing Ad Dollars to Twitter, Snap: Daniel Ives of GBH says that a number of factors are leading him to believe that Snap and Twitter’s growth prospects are improving relative to Facebook. Facebook’s recent move to keep its platform social could have had something to do with it.
In any case, 15-20% of traditional social media advertisers who have earlier only used Facebook, are now experimenting with Twitter ads.
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year.See these high-potential stocks free >>.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Amazon, Alphabet, Apple, Twitter and Facebook
For Immediate Release
Chicago, IL – March 2, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Amazon (AMZN - Free Report) , Alphabet (GOOGL - Free Report) , Apple (AAPL - Free Report) , Twitter and Facebook .
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Thursday’s Analyst Blog:
Tech Roundup: Amazon in Healthcare, Google Pay Launches
Amazon selling over the counter medications and Alphabet rebranding and enhancing Android Pay as Google Pay were the top stories from last week.
The Amazon Drug Store
CNBC reported that Amazon quietly launched a line of over-the-counter (OTC) medications and generic drugs under the Basic Care brand back in August. The 60 products sold under the brand are currently exclusively manufactured by private label Perrigo and also include some generics sold under its GoodSense brand.
Over the counter medications are everyday things like cough syrups, allergy medicines or treatments for minor stomach disorders that don’t require a prescription. People generally don’t buy them til the last minute, something that may not change despite Amazon’s competitive pricing. This is the main challenge for Amazon in the segment. They comprise 31%, or $8.4 billion, of the U.S. OTC medication industry, according to Euromonitor.
The bigger and more regulated part of the market is generics and while there have been news reports off and on about Amazon’s interest in the area, this market will be harder to break into. But once it manages to make an entry, it will be much easier to buy prescription medicines on Amazon, especially for chronic or prolonged illnesses. This might be why the company recently launched an alliance with JPMorgan Chase and Berkshire Hathaway with the stated objective of lowering healthcare costs for everyone over the long term.
Google Pay
As announced earlier, Google is rebranding Android Pay as Google Pay and also incorporating Google Wallet P2P (now called Google Pay Send) services into it. The app’s Home tab displays your recent transactions and based on your shopping history and location, lists nearby places that accept Google Pay. There’s also a Cards tab that stores your debt, credit and loyalty card information, as well as ongoing offers.
You can shift through these with your Google account information and don’t need to share card details. Other than the supported brick-and-mortar outlets, Google Pay also allows you to pay online on partner sites like Airbnb,DoorDash, Hotel Tonight and Fandango.
For people already using Android Pay, the shift will simply be a software update. The Google Pay Send integration will happen gradually over the next few months, first in the U.S. and UK.
Other Stories-
Corporate
Analysts Weigh in on Apple: According to various media reports, UBS analyst Steven Milunovich thinks that Apple will likely spend its billons by buying back shares or combining that with higher dividends to become cash neutral by 2023. Speculation started after In the first scenario, it buys back 10% of its shares each year resulting in a 30% increase in the EPS by 2021 and in the second, its spends $30-60 billion on share buybacks while increasing the dividend yield to 3% from 1.6%. The analyst doesn’t think there’s a big acquisition on the horizon.
Analyst Sees Facebook Losing Ad Dollars to Twitter, Snap: Daniel Ives of GBH says that a number of factors are leading him to believe that Snap and Twitter’s growth prospects are improving relative to Facebook. Facebook’s recent move to keep its platform social could have had something to do with it.
In any case, 15-20% of traditional social media advertisers who have earlier only used Facebook, are now experimenting with Twitter ads.
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year.See these high-potential stocks free >>.
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.